Jazz Pharmaceuticals made its cannabis drug ambitions clear last year with a $7.2 billion acquisition of GW Pharmaceuticals and again in March when it started building a plant in the U.K. designed ...
Pharma companies routinely sue generics makers for alleged patent infringement with their proposed copycats. But the fight over Jazz Pharmaceuticals' Epidiolex marks a more unique fight against ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback